Benzodiazepines: Revisiting Clinical Issues in Treating Anxiety Disorders

by Jerrold F. Rosenbaum, MD; Charles P. O’Brien, MD, PhD; Michael W. Otto, PhD; Mark H. Pollack, MD; Peter P. Roy-Byrne, MD; Samantha A. Stewart, MD

Forgot your login? GET HELP

First page of Academic Highlights: Benzodiazepines: Revisiting Clinical Issues in Treating Anxiety Disorders

Click to enlarge page

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Chair Jerrold F. Rosenbaum, M.D., began the meeting by explaining that he had been asked to be a discussant at a case conference at Massachusetts General Hospital where Samantha A. Stewart, M.D., presented the case of a woman (described herein by Dr. Stewart) who was admitted with cognitive deficits potentially caused by benzodiazepine abuse and dependence––issues that were heavily debated during the 1980s. Dr. Rosenbaum stated that the purpose of the meeting was to address concerns related to benzodiazepine use in clinical practice today.​

​

Prim Care Companion J Clin Psychiatry 2005;7(1):23-30

https://doi.org/10.4088/PCC.v07n0104

© Copyright 2005 Physicians Postgraduate Press, Inc.